Area of focus

Medical Devices

Creating and commercializing a cutting-edge medical device is demanding work. Remaining compliant in the face of ever increasing regulation makes that job even more difficult.

We leverage the vast experience gleaned from guiding companies of all sizes through the hard-to-navigate health care environment. We ask the right questions and explore uncovered possibilities to put your product in the best position for success.

  • Coverage and reimbursement
  • Financing, distribution, and other agreements
  • Good...

Representative experience

Obtaining the FDA’s designation of expedited review status for a novel orthopedic and women’s health device and negotiated favorable review timetables.

Managing PMA and Advisory Panel Process and helped secure approval for novel, noninvasive screening test using advanced DNA technology to detect colorectal cancer.

Drafting one of the first de novo submissions and obtaining multiple downclassifications and subsequent premarket clearances for capsule endoscopy imaging systems.

Assisting a client seeking FDA regulatory marketing approval of the first ever Retinal Prosthesis System intended for partial restoration of vision.

Conducting due diligence for investment bank on medical device startup, uncovering several important FDA issues that substantially altered the target’s valuation.

Assisting a client that manufactures an artificial heart to reverse Medicare’s national noncoverage decision and secure more advantageous Medicare reimbursements.

Advising a U.S.-based national trade association that provides educational assistance to medical technology companies in Chinese medical device reimbursement rules and policies.

Acting for a global medical device manufacturer on various claims regarding cardiac devices.

Advising a U.S. medical devices company on regulatory and commercial issues regarding the market launch of a gene test in 24 European countries.

Coordinating the defense of a manufacturer of implantable class III medical devices against alleged liability in clinical trials after a voluntary worldwide product withdrawal.

Assisting a medical device manufacturer with investigations by the authorities, criminal investigations, and civil proceedings arising out of the over-exposure of patients to radiations.

Representing a leading medical device manufacturer in a global recall of one of its products in more than 70 countries.

Counsel to a publicly traded company in a voluntary disclosure to USDOJ and the SEC regarding alleged payments to win public tenders and in follow-on litigation.

Represented a global technology company in the creation of a joint venture to develop next-generation surgical robots.

We have prepared more companies for panel meetings in the last two years than almost any other law firm or consultant in the country.

Hogan Lovells Publications

The 3-D printing revolution: Opening the doors to new opportunities — and risks associated with IP infringement

As the use of 3-D printing has increased exponentially, so has its potential. Stella Wong, counsel focusing on patent litigation at our Hogan Lovells office in London, compares a 3-D...

Quick view Full view

Press Releases

Hogan Lovells Advises on Groundbreaking FDA Grant of De Novo Request to Market a Novel Artificial Intelligence-based Device

Philadelphia / San Francisco, 16 April 2018 – IDx LLC, with assistance from Hogan Lovells, achieved a major grant of De Novo classification from the U.S. Food and Drug Administration...

Quick view Full view

Hogan Lovells Publications

What device companies need to know ahead of an advisory panel meeting

Preparing for advisory panel meetings For companies that manufacture new and novel medical devices, advisory panel meetings can be a crucial step toward receiving formal clearance or...

Quick view Full view

Hogan Lovells Publications

UK M&A: Brexit and investment in UK life sciences

While Brexit is likely to result in sweeping changes to the UK’s life sciences sector, the rate of M&A and foreign investment is a positive sign that the region will uphold its...

Quick view Full view

Hogan Lovells Publications

Best practices for managing cybersecurity risks related to IoT-connected medical devices

Connected medical devices deliver numerous benefits not available before, including improved monitoring of patient welfare and a wealth of vital data. But for all the advantages available...

Quick view Full view

Hogan Lovells Publications

FDA proposes rule to codify existing guidance on supervisory review of CDRH decisions

On January 17, 2018, the U.S. Food and Drug Administration (FDA or the Agency) issued a proposed rule to update the framework for requesting internal agency supervisory review of certain...

Quick view Full view
Loading data